Skip to content

Effect of anterior capsule block of shoulder joint combined with suprascapular nerve block on postoperative analgesia after arthroscopy of shoulder joint

Effect of anterior capsule block of shoulder joint combined with suprascapular nerve block on postoperative analgesia after arthroscopy of shoulder joint

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067537
Enrollment
Unknown
Registered
2023-01-10
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder joint disease

Interventions

SHAC+SSnb group :shoulder anterior capsule(SHAC) combined with a suprascapular nerve block(SSnb)
ISB group:conventional interscalene block(ISB)

Sponsors

The First Affiliated Hospital Of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Elective shoulder arthroscopy; 2, ASA classification I-II; 3. Age: 18-75 years old;

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Severe obesity (body mass index > 35kg/m2); 3. Restricted lung disease (1s forced expiratory volume < 50%); 4, regional anesthesia contraindications (such as local anesthesia allergy, coagulation disorders and local infection); 5. Diabetes; 6. Previous shoulder surgery or shoulder trauma; 7. Neuropathy or myopathy of the surgical limb on the affected side; 8, chronic opioid use history; 9. Pain score cannot be understood; 10, the use of steroids treatment patients; 11, received a non-surgical treatment of patients; 12, don't agree with the use of intravenous patient-controlled analgesia pump patients.

Design outcomes

Primary

MeasureTime frame
Pain intensity at rest 4h after surgery;

Secondary

MeasureTime frame
Incidence and level of dyspnea and discomfort related to muscle weakness;Pain score at rest on the first night after operation;Dosage of sufentanil;Motor block time;Clarity of surgical field and satisfaction of surgeon;

Countries

China

Contacts

Public ContactLiqin Cheng
2235616728@qq.com13968849974

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026